Combinatorial therapy in tumor microenvironment: Where do we stand?

Area of Science:

• Oncology
• Cancer Biology
• Immunology

Background:

• The tumor microenvironment (TME) is crucial for tumor initiation and progression.
• It comprises diverse cellular and non-cellular components that support cancer cell proliferation.
• Understanding TME dynamics is key to overcoming therapeutic challenges like drug resistance and immune escape.

Purpose of the Study:

• To review the composition and interactions within the tumor microenvironment.
• To explore the potential of targeting the TME as a novel cancer therapeutic strategy.
• To discuss the status and advancements of combinatorial therapies for cancer treatment.

Main Methods:

• Literature review of tumor microenvironment composition and function.
• Analysis of current combinatorial therapeutic approaches in cancer.
• Evaluation of barriers and regulatory aspects of developing combination regimens.

Main Results:

• The TME significantly influences cancer cell growth, progression, and therapeutic response.
• Combinatorial therapies, integrating modalities like chemotherapy, immunotherapy, and nanotherapy, show promise for synergistic anti-cancer effects.
• Computational tools can aid in monitoring therapy outcomes.

Conclusions:

• Targeting the tumor microenvironment presents a viable strategy to enhance cancer therapeutics.
• Overcoming treatment failure necessitates combinatorial approaches that synergistically target cancer pathways.
• Further research into TME biology will drive the development of effective novel cancer therapies.